Skip to main content

Advertisement

Table 2 Summary demographics of the independent neurologically normal CSF/serum matched cohort

From: CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

  n Gender (M:F) Age (mean years ± SD) Albumin ratio
CSF/serum cohort 23 12:11 58.13 ± 20.25 9.04 ± 1.19